JP2008503581A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2008503581A5 JP2008503581A5 JP2007518179A JP2007518179A JP2008503581A5 JP 2008503581 A5 JP2008503581 A5 JP 2008503581A5 JP 2007518179 A JP2007518179 A JP 2007518179A JP 2007518179 A JP2007518179 A JP 2007518179A JP 2008503581 A5 JP2008503581 A5 JP 2008503581A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- aequorin
- subject
- composition according
- agent
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US10/872,795 | 2004-06-21 | ||
| US10/872,795 US20060229243A1 (en) | 2004-06-21 | 2004-06-21 | Aequorin-containing compositions and methods of using same |
| PCT/US2005/021770 WO2006010004A2 (en) | 2004-06-21 | 2005-06-21 | Aequorin-containing compositions and methods of using same |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2008503581A JP2008503581A (ja) | 2008-02-07 |
| JP2008503581A5 true JP2008503581A5 (enExample) | 2008-07-24 |
| JP4971150B2 JP4971150B2 (ja) | 2012-07-11 |
Family
ID=35785748
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2007518179A Expired - Fee Related JP4971150B2 (ja) | 2004-06-21 | 2005-06-21 | イクオリン−含有組成物及びその使用方法 |
Country Status (20)
| Country | Link |
|---|---|
| US (3) | US20060229243A1 (enExample) |
| EP (2) | EP1768691B1 (enExample) |
| JP (1) | JP4971150B2 (enExample) |
| KR (1) | KR101213555B1 (enExample) |
| CN (1) | CN1997383B (enExample) |
| AU (1) | AU2005265266B2 (enExample) |
| BR (1) | BRPI0512392B1 (enExample) |
| CA (1) | CA2571542C (enExample) |
| CY (1) | CY1114307T1 (enExample) |
| DK (1) | DK1768691T3 (enExample) |
| ES (1) | ES2422173T3 (enExample) |
| IL (1) | IL180195A (enExample) |
| MX (1) | MXPA06015037A (enExample) |
| NZ (1) | NZ552274A (enExample) |
| PL (1) | PL1768691T3 (enExample) |
| PT (1) | PT1768691E (enExample) |
| SG (1) | SG153848A1 (enExample) |
| SI (1) | SI1768691T1 (enExample) |
| WO (1) | WO2006010004A2 (enExample) |
| ZA (1) | ZA200610688B (enExample) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20060229243A1 (en) * | 2004-06-21 | 2006-10-12 | Quincy Resource Group, Inc. | Aequorin-containing compositions and methods of using same |
| GB0625678D0 (en) | 2006-12-21 | 2007-01-31 | Lux Biotechnology Ltd | Composition and method for detection of demineralisation |
| BRPI0909435A2 (pt) * | 2008-03-11 | 2017-06-13 | Quincy Bioscience Llc | composição e método para tratar de um sintoma ou distúrbio associado com o desequilíbrio do cálcio, uso da apoequorina, e, apoaequorina |
| JP2010143860A (ja) * | 2008-12-19 | 2010-07-01 | Chisso Corp | タンパク質の安定化剤 |
| US20110130336A1 (en) * | 2009-10-16 | 2011-06-02 | Quincy Bioscience, Llc | Method of treating ischemic injury using apoaequorin |
| CA2822594A1 (en) * | 2010-12-24 | 2012-06-28 | Otsuka Pharmaceutical Co., Ltd. | Bioassay method for detecting physiologically active substance |
| WO2013074798A1 (en) * | 2011-11-15 | 2013-05-23 | Quincy Bioscience, Llc | Apoaequorin for reducing neuronal injury due to ischemia |
| GB201700317D0 (en) | 2017-01-09 | 2017-02-22 | Calcivis Ltd | Detection device |
| USD1042180S1 (en) | 2020-05-28 | 2024-09-17 | Calcivis Limited | Dental detection device |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2001240855A (ja) * | 2000-03-01 | 2001-09-04 | Masashi Sugimoto | 生物発光方法及び発光物品 |
| US6800492B2 (en) * | 2000-06-01 | 2004-10-05 | Institute Pasteur | Chimeric GFP-aequorin as bioluminescent Ca++ reporters at the single cell level |
| US6930169B2 (en) * | 2000-06-12 | 2005-08-16 | University Of Baltimore Biotechnology Institute | Method of controlling the binding of calmyrin to presenilin |
| US20060229243A1 (en) * | 2004-06-21 | 2006-10-12 | Quincy Resource Group, Inc. | Aequorin-containing compositions and methods of using same |
-
2004
- 2004-06-21 US US10/872,795 patent/US20060229243A1/en not_active Abandoned
-
2005
- 2005-06-21 PL PL05766584T patent/PL1768691T3/pl unknown
- 2005-06-21 US US11/571,043 patent/US7671015B2/en not_active Expired - Lifetime
- 2005-06-21 WO PCT/US2005/021770 patent/WO2006010004A2/en not_active Ceased
- 2005-06-21 CN CN200580024585XA patent/CN1997383B/zh not_active Expired - Lifetime
- 2005-06-21 SI SI200531724T patent/SI1768691T1/sl unknown
- 2005-06-21 KR KR1020077001461A patent/KR101213555B1/ko not_active Expired - Lifetime
- 2005-06-21 NZ NZ552274A patent/NZ552274A/en not_active IP Right Cessation
- 2005-06-21 EP EP05766584.6A patent/EP1768691B1/en not_active Expired - Lifetime
- 2005-06-21 DK DK05766584.6T patent/DK1768691T3/da active
- 2005-06-21 MX MXPA06015037A patent/MXPA06015037A/es active IP Right Grant
- 2005-06-21 AU AU2005265266A patent/AU2005265266B2/en not_active Expired
- 2005-06-21 EP EP12188025.6A patent/EP2545934B1/en not_active Expired - Lifetime
- 2005-06-21 BR BRPI0512392-5A patent/BRPI0512392B1/pt not_active IP Right Cessation
- 2005-06-21 ES ES05766584T patent/ES2422173T3/es not_active Expired - Lifetime
- 2005-06-21 CA CA2571542A patent/CA2571542C/en not_active Expired - Lifetime
- 2005-06-21 JP JP2007518179A patent/JP4971150B2/ja not_active Expired - Fee Related
- 2005-06-21 PT PT57665846T patent/PT1768691E/pt unknown
- 2005-06-21 SG SG200904273-0A patent/SG153848A1/en unknown
-
2006
- 2006-12-19 ZA ZA200610688A patent/ZA200610688B/en unknown
- 2006-12-19 IL IL180195A patent/IL180195A/en active IP Right Grant
-
2010
- 2010-01-27 US US12/694,427 patent/US20100152117A1/en not_active Abandoned
-
2013
- 2013-06-14 CY CY20131100486T patent/CY1114307T1/el unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2023503309A5 (enExample) | ||
| HRP20220902T3 (hr) | Pripravci i njihova upotreba u liječenju multiple skleroze | |
| JP2012236849A5 (enExample) | ||
| CN102068682A (zh) | 一种治疗消化系统疾病的中药组合物及其制备方法 | |
| HRP20150375T1 (hr) | Derivati piridazinona | |
| FI3710000T3 (fi) | Tradipitantti käytettäväksi gastropareesin hoidossa | |
| RU2010142456A (ru) | Синергические комбинации 5'-метилтиоаденозина | |
| JP2003238444A5 (enExample) | ||
| Sheffer et al. | Cetirizine: antiallergic therapy beyond traditional H1 antihistamines | |
| CN104547826B (zh) | 高良姜提取物治疗痛经的医药用途 | |
| KR100878436B1 (ko) | 금은화 추출물을 포함하는 소화성 궤양 치료 또는 예방용 약학조성물 | |
| RU2007119067A (ru) | Средство для лечения синдрома раздраженного кишечника с преобладанием диареи | |
| CN105997970A (zh) | γ-氨基丁酸在制备胃粘膜保护剂中的应用 | |
| RU2006139819A (ru) | Применение симетикона для предрасположенных к запорам пациентов | |
| RU2222305C1 (ru) | Дорожная аптечка общего назначения | |
| JP2022533251A (ja) | 患者において血清リン酸塩を低下させるための組み合わせ | |
| JP2003523385A5 (enExample) | ||
| CN101406496A (zh) | 一种治疗前列腺炎及其它男性生殖系统疾病的配方 | |
| CN100506239C (zh) | 治疗带状疱疹的中药制剂及制备方法 | |
| RU2004121780A (ru) | Способ лечения | |
| CN103623042A (zh) | 一种景天清肺药物组合物在制备抗甲型流感病毒药物中的应用 | |
| CN101579482A (zh) | 一种治疗高血压的药物组合物及其制备方法 | |
| CN109966291A (zh) | 化合物sb216763在制备预防和/或治疗脑血管疾病的药物中的应用及其药物组合物 | |
| CN102512652B (zh) | 一种治疗消化性溃疡的药物组合物 | |
| CN102973906A (zh) | 一种胃疡灵及其制备方法 |